Clinical protein science in translational medicine targeting malignant melanoma.

MLA

Gil, Jeovanis, et al. “Clinical Protein Science in Translational Medicine Targeting Malignant Melanoma.” Cell Biology and Toxicology, vol. 35, no. 4, Aug. 2019, pp. 293–332. EBSCOhost, https://doi.org/10.1007/s10565-019-09468-6.

APA

Gil, J., Betancourt, L. H., Pla, I., Sanchez, A., Appelqvist, R., Miliotis, T., Kuras, M., Oskolas, H., Kim, Y., Horvath, Z., Eriksson, J., Berge, E., Burestedt, E., Jönsson, G., Baldetorp, B., Ingvar, C., Olsson, H., Lundgren, L., Horvatovich, P., … Marko-Varga, G. (2019). Clinical protein science in translational medicine targeting malignant melanoma. Cell Biology and Toxicology, 35(4), 293–332. https://doi.org/10.1007/s10565-019-09468-6

Chicago

Gil, Jeovanis, Lazaro Hiram Betancourt, Indira Pla, Aniel Sanchez, Roger Appelqvist, Tasso Miliotis, Magdalena Kuras, et al. 2019. “Clinical Protein Science in Translational Medicine Targeting Malignant Melanoma.” Cell Biology and Toxicology 35 (4): 293–332. doi:10.1007/s10565-019-09468-6.